The report from the CEA’s own investigation of the company’s collapse is awaited
Sandyford-based Hibergene was once billed as an up-and-coming star of Irish medtech, after its diagnostic kits became prominent during the Covid pandemic.
But when the an Enterprise Ireland-backed firm – which had raised an estimated €12m from investors – was placed into liquidation by its board, management blamed “disgruntled” shareholders, claiming that they had spooked potential investors.
A group of unhappy shareholders had held an extraordinary general meeting in the months ahead of the liquidation and voiced serious concerns about the firm, later seeking to have their own liquidator appointed.
An outcome from the CEA’s own investigation…
